Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy.
Cancer
; 117(21): 5013-20, 2011 Nov 01.
Article
em En
| MEDLINE
| ID: mdl-21456017
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Quinazolinas
/
Neoplasias da Mama
/
Receptor ErbB-2
/
Antineoplásicos
Tipo de estudo:
Risk_factors_studies
Limite:
Female
/
Humans
Idioma:
En
Ano de publicação:
2011
Tipo de documento:
Article